Experimentation With Screening for Bronchopulmonary Cancer and Primary Cardiovascular Prevention, Early Management of COPD and an Offer Exempted From Smoking Cessation

Launched by CENTRE HOSPITALIER INTERCOMMUNAL CRETEIL · Jun 27, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how effective a screening program can be for detecting bronchopulmonary cancer (a type of lung cancer) and preventing heart disease in people with a history of smoking. Researchers want to see how many people will participate in this program, which involves sending letters to potential participants in the Ile de France region. If you are between 55 and 74 years old, have a significant history of smoking, and have not smoked in the last 15 years, you may be eligible to join the study.

Participants in this trial will undergo a series of medical examinations at the start and then again at one, two, three, four, and five years later. These check-ups will help monitor lung health and any potential signs of cancer or heart disease. It’s important to know that some individuals will not be able to participate, such as those currently being treated for bronchopulmonary cancer or those with serious health issues that could affect their survival. If you think you might qualify or are interested in learning more, please keep an eye out for the recruitment phase to begin!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Women and men
• • Age: 55 to 74 years old
• • Smokers at more than 20 pack-years weaned for less than 15 years
• • Affiliated to a social security organization
• Exclusion Criteria:
• • Presence of signs of PBC
• • Subjects with a personal history of PBC of less than 5 years or under treatment
• • Presence of serious comorbidities involving the vital prognosis at 6 months
• • Subjects who have already benefited from a chest CT scan less than one year old.
• • Refusal to participate in the study
• • Absence of exposure to tobacco or insufficient exposure to tobacco or withdrawal \> 15 years
• • Patient on long-term oxygen therapy
• • Metal implants (thorax, spine) which can cause a deterioration in the quality of the image of the low dose scanner
• • Subject included in another study protocol